OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of fluvastatin ER 80 mg compared with fluvastatin IR 40 mg in the treatment of primary hypercholesterolaemia

HTML

Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Cardiology
Authors: William Insull, A. David Marais, Ronnie Aronson, S Manfreda, Jacques Bedard, Steven M. Bowman, Hillary Browne, Lesley Burgess, Albert A. Carr, Lydia G. Corn, Ian H. Craig, David M. Cross, Salah El Hafi, Thomas G. Elliot, Jean Firth, Jonathan L. Isaacsohn, Charlotte Jones, Sezer Müniboğlu Karcier, Jon LeLevier, Robert Lipetz, Leif A. Lohrbauer, Albert Oberman, Richard O’Brien, Terry L. Poling, M C Rajput, Cindy Jo Richard, Russell Scott, Sırrı Kes, Diane Smith, İnan Soydan, J Terblanche, Karen Wolmarans
Institution: University of Cape Town
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: fluvastatin, sustained-release formulation, immediate-release formulation, primary hypercholesterolemia, LDL cholesterol lowering, HDL cholesterol, apolipoprotein A-I, apolipoprotein B, triglycerides, lipid-lowering therapy, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2524935901
FWCI: 0.413
Cites:
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security